Table 5.
S.N. | Study model | Treatment | Mode of inhibition | Observations | References |
---|---|---|---|---|---|
1 | Pilocarpine-induced SE mouse model | GL | Release inhibition | Decreases levels of malondialdehyde and glutathione in brain regions | (82) |
2 | Pilocarpine-induced epilepsy mouse model | anti-HMGB1 mAb | Neutralization | Attenuates damage such as increased intracellular space in the hippocampus caused by seizures in epileptic mice | (83) |
3 | Pentylenetetrazol-induced epilepsy zebrafish model | GL | Release inhibition | Anticonvulsant Inhibits HMGB1/TLR4/NF-κB signaling pathway |
(84) |
4 | Lithium-pilocarpine induced epilepsy mouse model | GL | Release inhibition | Inhibits the translocation of HMGB1 from the nucleus to the cytoplasm Improves the neuronal damage in the CA1 and CA3 regions of the hippocampus after SE Protects BBB |
(85) |